Updated treatment guidelines and the availability of the ResistancePlus® GC test for Neisseria gonorrhoeae from SpeeDx, are making it possible for patients with gonorrhoea to be treated with the cheap and easily-administered oral antibiotic ciprofloxacin.
“The new guideline now recommends giving double the previously recommended dose of ceftriaxone (now 1g stat),” says John White, MD, consultant in sexual health and HIV at the Altnagelvin Hospital and editor-in-chief of the International Journal of STDs & AIDS. “However, they also indicate ciprofloxacin as a first-line option when antimicrobial susceptibility is known prior to treatment.”
Such treatment is less painful for patients and is also preferred by doctors, as it is a cheaper treatment that does not require specialized staff to administer the injection.
“If we can use less ceftriaxone this may also help to stall the further development and dissemination of ceftriaxone-resistant strains within Europe,” White adds.
read the full CLPmag article here.